Author: Friedland, Julian
Source: Leeds School of Business
Number of pages: 2
A new prescription drug is pushed through the FDA approval process despite evidence that it may have widespread negative side effects. This case is part of a series of cases in Business & Society from the Leeds School of Business. The series provides both actual and fictional situations which illustrate ethical issues in business and is designed to prompt discussion in college classes. This series is provided without charge to educators for noncommercial use through financial support from the George and Judy Writer family and the Leeds School of Business.
A Lethal Prescription (284k)